- Antoni, S., Ferlay, J., Soerjomataram, I., Znaor, A., Jemal, A., & Bray, F. (2017). Bladder cancer incidence and mortality: a global overview and recent trends. European urology, 71(1), 96-108.
- Ferlay J, Shin H R, Bray F et al., (2008): Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10. Lyon, France: International Agency for Research on Cancer.
- Helal, T., Salman, M., & Ezz-Elarab, S. (2015). Pathology-based cancer registry 2001-2010. Chapter, 4, 17-25.
- ElMoneim, H. M. A., Tawfik, H. M., El Sherbiny, Y. M., & Tawfiek, E. R. (2011). Analysia of Her2/neu overexpression and amplification in urothelial carcinoma of the bladder associated with Cox-2 overexpression. Int J Cancer Res, 7(1), 8-24.
- Johansson, H., Andersson, R., Bauden, M., Hammes, S., Holdenrieder, S., & Ansari, D. (2016). Immune checkpoint therapy for pancreatic cancer. World journal of gastroenterology, 22(43), 9457.
- Postow, M. A., Callahan, M. K., & Wolchok, J. D. (2015). Immune checkpoint blockade in cancer therapy. Journal of Clinical Oncology, 33(17), 1974.
- Bidnur, S., Savdie, R., & Black, P. (2016). Inhibiting immune checkpoints for the treatment of bladder cancer. Bladder Cancer, 2(1), 15-25.
- Carosella, E. D., Ploussard, G., LeMaoult, J., & Desgrandchamps, F. (2015). A systematic review of immunotherapy in urologic cancer: evolving roles for targeting of CTLA-4, PD-1/PD-L1, and HLA-G. European urology, 68(2), 267-279.
- Zou, W., & Chen, L. (2008). Inhibitory B7-family molecules in the tumour microenvironment. Nature Reviews Immunology, 8(6), 467-477.
- Purdie, C., Quinlan, P., Jordan, L., Ashfield, A., Ogston, S., Dewar, J., & Thompson, A. (2014). Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study. British journal of cancer, 110(3), 565.
- Boorjian, S. A., Sheinin, Y., Crispen, P. L., Farmer, S. A., Lohse, C. M., Kuntz, S. M. & Frank, I. (2008). T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival. Clinical Cancer Research, 14(15), 4800-4808.
- Herbst, R. S., Soria, J.-C., Kowanetz, M., Fine, G. D., Hamid, O., Gordon, M. S. & Gettinger, S. N. (2014). Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients. Nature, 515(7528), 563.
- Moch, H., Humphrey, P., Ulbright, T., & Reuter, V. (2016b). Tumours of the urinary tract. WHO Classification of Tumours of the Urinary System and Male Genital Organs, 4th ed. Lyon, France: IARC.
- Amin, M. B., Greene, F. L., Edge, S. B., Compton, C. C., Gershenwald, J. E., Brookland, R. K. & Winchester, D. P. (2017). The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging. CA: a cancer journal for clinicians, 67(2), 93-99.
- Bellmunt, J., Mullane, S., Werner, L., Fay, A., Callea, M., Leow, J. & Freeman, G. (2015). Association of PD-L1 expression on tumor-infiltrating mononuclear cells and overall survival in patients with urothelial carcinoma. Annals of Oncology, 26(4), 812-817.
- Faraj, S. F., Munari, E., Guner, G., Taube, J., Anders, R., Hicks, J. & Drake, C. (2015). Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinoma. Urology, 85(3), 703. e701-703. e706.
- Mukamel E, Shohat B, Servadio C. Immunological profile of patients with transitional cell carcinoma of the bladder. Br J Urol. 1982;54:11–15
- Inman, B. A., Sebo, T. J., Frigola, X., Dong, H., Bergstralh, E. J., Frank, I. & Kwon, E. D. (2007). PD‐L1 (B7‐H1) expression by urothelial carcinoma of the bladder and BCG‐induced granulomata: associations with localized stage progression. Cancer: Interdisciplinary International Journal of the American Cancer Society, 109(8), 1499-1505.
- Nakanishi, J., Wada, Y., Matsumoto, K., Azuma, M., Kikuchi, K., & Ueda, S. (2007). Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers. Cancer Immunology, Immunotherapy, 56(8), 1173-1182.
- Thompson, R. H., Dong, H., & Kwon, E. D. (2007). Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapy. Clinical Cancer Research, 13(2), 709s-715s
|